My Cart [ 0 ]
Home > Antibodies > Anti-Mouse Antibodies (In Vivo) > Anti-Mouse CD8a Monoclonal Antibody (Clone: 2.43)

Anti-Mouse CD8a Monoclonal Antibody (Clone: 2.43)

CD8 alpha, T-cell surface glycoprotein CD8 alpha chain, CD_antigen CD8a

Catalog No. Product Name Size List Price (US$) Quantity
PA007167.r2b In Vivo Grade Recombinant Anti-Mouse CD8a Monoclonal Antibody (Clone 2.43), Rat IgG2b Kappa 1 mg 150.00
PA007167.r2b In Vivo Grade Recombinant Anti-Mouse CD8a Monoclonal Antibody (Clone 2.43), Rat IgG2b Kappa 5 mg 350.00
PA007167.r2b In Vivo Grade Recombinant Anti-Mouse CD8a Monoclonal Antibody (Clone 2.43), Rat IgG2b Kappa 25 mg 900.00
PA007167.m2a In Vivo Grade Recombinant Anti-Mouse CD8a Monoclonal Antibody (Clone 2.43), Mouse IgG2a Kappa 1 mg 150.00
PA007167.m2a In Vivo Grade Recombinant Anti-Mouse CD8a Monoclonal Antibody (Clone 2.43), Mouse IgG2a Kappa 5 mg 350.00
PA007167.m2a In Vivo Grade Recombinant Anti-Mouse CD8a Monoclonal Antibody (Clone 2.43), Mouse IgG2a Kappa 25 mg 900.00
Description

Background of Recombinant Anti-Mouse CD8a Monoclonal Antibody (Clone 2.43)

The rat anti-mouse CD8a monoclonal antibody clone 2.43 (also widely referred to as anti-Lyt-2 antibody) specifically reacts with the mouse CD8a protein—a T-cell surface glycoprotein encoded by the CD8A gene. As a critical component of the dimeric CD8 protein, CD8a is essential for cell-mediated immune defense and T-cell development. Beyond its physiological role, CD8A is recognized as a vital diagnostic and prognostic marker in inflammatory disorders and various tumor models.

Our in vivo grade recombinant anti-mouse CD8a monoclonal antibody (clone 2.43) is engineered to provide superior performance over traditional hybridoma-derived products. By utilizing a low endotoxin production platform, we ensure that each batch meets stringent requirements for in vivo CD8+ T cell depletion assays. Our recombinant 2.43 antibodies possess the complete amino acid sequences of the original hybridoma clone, guaranteeing high-fidelity binding, exceptional batch-to-batch consistency, and the reliability required for pristine, publication-ready research datasets.

PA007167.r2b: In Vivo Grade Recombinant Anti-Mouse CD8a Monoclonal Antibody (Clone 2.43), Rat IgG2b Kappa

The in vivo grade recombinant anti-mouse CD8a rat IgG2b monoclonal antibody was produced in mammalian cells.
Specificity: CD8a.
Clone: 2.43.
Isotype: rat IgG2b, kappa.
Applications: Western blot, immunohistochemistry (IHC), Flow Cytometry (FC), and in vivo CD8+ T cell depletion.
Formulation: 0.2 μM filtered solution of 1x PBS.
Purity: >95% by SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.
RRID: AB_3697157

PA007167.m2a: In Vivo Grade Recombinant Anti-Mouse CD8a Monoclonal Antibody (Clone 2.43), Mouse IgG2a Kappa

The in vivo grade recombinant anti-mouse CD8a mouse IgG2a monoclonal antibody was produced in mammalian cells.
Specificity: CD8a.
Clone: 2.43.
Isotype: mouse IgG2a, kappa.
Applications: Western blot, immunohistochemistry (IHC), Flow Cytometry (FC), and in vivo CD8+ T cell depletion.
Formulation: 0.2 μM filtered solution of 1x PBS.
Purity: >95% by SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.

Shipping: The in vivo grade recombinant anti-mouse CD8a antibodies (clone of 2.43) are shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
1 month from date of receipt, 2 to 8°C as supplied.
12 months from date of receipt, -20°C to -70°C as supplied.

References for Anti-Mouse CD8a Monoclonal Antibody (Clone: 2.43)

Balogh, K. N., et al. PLoS One. 2018 Jun 4;13(6):e0197702. PMID: 29864117
Mice were treated with an initial dose of 200 µg of anti-CD8 (clone 2.43) antibody in PBS, followed by 100 µg every 4 days. This study demonstrates the efficacy of clone 2.43 in sustained in vivo depletion protocols, confirming its reliability in tumor growth inhibition assays.
(Tags: Anti-Mouse CD8a Antibody 2.43; In Vivo CD8 depletion; Clone 2.43; Cancer Immunotherapy)
Voron, T., et al. J Exp Med. 2015 Feb 9;212(2):139-48. PMID: 25601652
For CD8+ T cell depletion, anti-CD8 antibody (clone 2.43) was administered at 100 µg i.p. to CT26-tumor bearing mice. The depletion efficiency was validated via flow cytometry, confirming clone 2.43 as a gold-standard reagent for verifying T cell checkpoint functionality.
(Tags: Anti-Mouse CD8a 2.43; In Vivo CD8+ T Cell Depletion; Checkpoint Inhibition Study)
Li, J., et al. Immunity. 2018 Apr 17;48(4):773-786.e5. PMID: 29625896
To deplete CD8+ T cells in the A20 tumor model, 100 µg of anti-CD8 (clone 2.43) was injected i.p. on a strategic schedule (Day -1, 2, 7, 12, 17). This robust protocol achieved depletion efficiencies of up to 85%, providing clear evidence of clone 2.43's utility in multi-dose, long-term in vivo experimental designs.
(Tags: Anti-Mouse CD8a 2.43; Recombinant Anti-CD8; In Vivo Depletion Protocol)
For more technical references or data sheets regarding the Recombinant Anti-Mouse CD8a Monoclonal Antibody (Clone 2.43) formats, please contact our scientific support team at message@sydlabs.com.

Frequently Asked Questions (FAQ) about Recombinant Anti-Mouse CD8a Antibody (Clone: 2.43)

Q: Can I use clone 2.43 for in vivo CD8+ T cell depletion?

Yes, clone 2.43 is the gold-standard antibody for in vivo CD8+ T cell depletion in mouse models. Syd Labs provides a recombinant, sequence-defined, low-endotoxin version of clone 2.43, engineered to ensure high depletion efficiency (>90%) with minimal non-specific immune activation.

Q: What is the recommended mouse CD8+ T cell depletion protocol and clone 2.43 injection dosage in vivo?

For an optimal mouse CD8+ T cell depletion protocol, typical dosage ranges from 100 µg to 500 µg per mouse per intraperitoneal (i.p.) injection, depending on your specific model (e.g., tumor suppression vs. viral infection). Consistency in injection frequency (e.g., every 3-4 days) is key to maintaining sustained depletion levels. Please refer to our "References" section for validated protocols utilized in published experimental models.

Q: Do I need an isotype control when using clone 2.43 for depletion?

Yes, incorporating an isotype control is critical to distinguish target-specific depletion effects from Fc-receptor-mediated background noise. We strongly recommend using our highly purified rat IgG2b or mouse IgG2a isotype controls, precisely matching the isotype of your selected 2.43 product, to ensure your experimental readouts are statistically robust and publication-ready.

Q: Why choose recombinant 2.43 over traditional hybridoma-derived antibodies?

Traditional hybridoma lines are highly susceptible to genetic drift, chromosomal loss, and inherent batch-to-batch variation. Syd Labs' recombinant anti-mouse CD8a 2.43 is produced in mammalian cells, ensuring absolute sequence consistency. This advanced platform guarantees ultra-low endotoxin levels (<1 EU/mg), eliminating the toxicity often seen with traditional hybridoma formats and making it the superior choice for reproducible research.

Q: How do I verify CD8 depletion efficiency in my mouse model?

The most widely accepted standard approach is to perform Flow Cytometry (FC) analysis on peripheral blood, spleen, or lymph node cell suspensions 24-48 hours after the initial injection. Important: You must use a different non-competing anti-CD8a clone (such as clone 53-6.7) for your fluorescent staining to accurately quantify the remaining T cells without competitive interference from the depleting 2.43 antibody.

Q: How should I cite this antibody in my research publication?

When publishing your research using this product, please cite our antibody as: "Recombinant Anti-Mouse CD8a Monoclonal Antibody (Syd Labs, Cat# PA007167.r2b; RRID: AB_3697157)." (Note: If using the mouse IgG2a variant, please update the Cat# to PA007167.m2a).

In Vivo Grade Recombinant Anti-Mouse CD8a Monoclonal Antibodies (Clone 2.43):
In Vivo Grade Recombinant Anti-Mouse CD8a Mouse IgG2a Monoclonal Antibody
In Vivo Grade Recombinant Anti-Mouse CD8a Mouse Fab Fragment
In Vivo Grade Recombinant Anti-Mouse CD8a Rat IgG2b Monoclonal Antibody

Syd Labs provides the following recombinant anti-human CD8a monoclonal antibodies:
In vivo grade recombinant anti-human CD8a antibodies (clone OKT8)
Recombinant anti-human CD8a antibodies (clone OKT8) for flow cytometry

Syd Labs provides the following recombinant anti-mouse CD8a monoclonal antibodies:
In vivo grade recombinant anti-mouse CD8a antibodies (clone 2.43)
In vivo grade recombinant anti-mouse CD8a antibodies (clone YTS 169.4)
In vivo grade recombinant anti-mouse CD8a antibodies (clone YTS 105.18)

Syd Labs provides the following recombinant anti-mouse CD8b monoclonal antibodies:
In vivo grade recombinant anti-mouse CD8b antibodies (clone YTS 156.7)

Related Links

See our Privacy Policy